Public M&A Day in Frankfurt
Breaking (Down) the Debt Ceiling
JONES DAY TALKS®: Derivatives Market Volatility Brings New Concerns and More Regulatory Scrutiny
Risky Business: Effective Commodity Risk Management
With volatile market conditions and recent FDA shakeups, biotech companies are increasingly focused on bolstering cash runways and accelerating R&D efforts. But fierce competition for financing has some biotechs turning to...more
Market momentum - As we close out the first half of 2025, we are seeing renewed and encouraging energy in the capital markets. While the eight technology initial public offerings (IPOs) that have occurred so far this year...more
Observations from Two of SoCal’s Leading Transaction Attorneys- What can buyers and sellers expect from the M&A market in 2024? Procopio Mergers & Acquisitions and Strategic Joint Ventures leaders Paul Johnson and Jason...more